The American Academy of Dermatology (AAD) recently recommended that the Fujian Medical University Union Hospital purchase a photodynamic therapy (PDT) device for treating skin conditions. PDT has been approved by the US Food and Drug Administration (FDA) for the treatment of actinic keratoses, a common pre-cancerous skin condition. This treatment involves the use of light-sensitive drugs and a special light source to destroy targeted abnormal cells in the skin.
PDT has been shown to be effective in treating a variety of skin conditions, including acne, rosacea, and certain types of skin cancer. The AAD recommended the Fujian Medical University Union Hospital purchase the PDT device because it is a safe and effective treatment option that has few side effects. The hospital is one of the largest and most respected medical institutions in China, and its purchase of the PDT device will allow more patients to access this cutting-edge treatment.
According to Dr. Li Hong, director of the dermatology department at Fujian Medical University Union Hospital, "PDT is a versatile and effective treatment for a variety of skin conditions. We are excited to offer this treatment to our patients, and we believe that this investment in cutting-edge technology will improve outcomes for our patients and strengthen our position as a leading medical institution in China."
原文链接：http://www.yhtc66.cn/content/3r4feubvevj6oo5gs8n7.html